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Abstract
Background: Surgical drainage is a rapid and effective treatment for pericardial tamponade in cancer patients. We
aimed to investigate the effectiveness of pericardial window formation via mini-thoracotomy for treating pericardial
tamponade in cancer patients, and to evaluate clinical factors affecting long-term survival.
Methods: Records of 53 cancer patients with pericardial tamponade treated by pericardial window formation
between 2002 and 2008 were examined. Five patients were excluded due to insufficient data. Kaplan-Meier and
Cox regression analysis were used for analysis.
Results: Forty-eight patients (64.7% male), with a mean age of 55.20 ± 12.97 years were included. Patients were
followed up until the last control visit or death. There was no surgery-related mortality and the 30-day mortality
rate was 8.33%; all died during postoperative hospitalization. Morbidity rate was 18.75%. Symptomatic recurrence
rate was 2.08%. Cancer type and nature of the pericardial effusion were the major factors determining long-term
survival (P <0.001 and P <0.004, respectively).
Overall median survival was 10.41 ± 1.79 months. One- and 2-year survival rates were 45 ± 7% and 18 ± 5%,
respectively.
Conclusion: Pericardial window creation via minithoracotomy was proven to be a safe and effective approach in
surgical treatment of pericardial tamponade in cancer patients. Cancer type and nature of pericardial effusion were
the main factors affecting long-term survival.
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Background
The prevalence of pericardial tamponade requiring surgical
intervention is not uncommon in cancer patients and it is
a life-threatening problem. It is possible to overcome this
problem, prolong survival, and improve the quality of life
of patients by effective management strategies. The essence
of management is to achieve minimal morbidity and long-
term survival without procedure-related mortality. The ef-
fectiveness of creating a pericardiopleural window via left
minithoracotomy for the surgical treatment of pericardial
tamponade in cancer patients, and the associated risk fac-
tors affecting long-term survival were investigated in this
study.
Methods
A total of 48 consecutive cancer patients with pericardial
tamponade treated by creating a pericardial window via
left mini-thoracotomy between February 2002 and Janu-
ary 2008 in our clinic were included in the study. The
study was approved by the Local Ethics Committee.
Patients, who underwent pericardiocentesis alone, those
who had sclerotherapy along with pericardiocentesis,
and those who were concurrently diagnosed with peri-
cardial tamponade along with malignity, were excluded.
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During the study period, 22 patients with symptomatic
pericardial effusion were treated by pericardiocentesis
alone with no recurrence. These patients were directed
to chemotherapy and mediastinal radiotherapy.
The mean age of the patients was 55.20 ± 12.97 years
(range, 25–73 years), and 16 (33%) were female and 32
(64.7%) were male. All clinical information including the
surgical procedure and complications, preoperative and
postoperative echocardiography findings, cytopathologi-
cal, cytogenetic, bacteriological, viral and immunological
results, and patient outcome was retrospectively
reviewed from patient files.
The diagnosis of pericardial tamponade was based on
clinical features as well as the presence of at least one of
the following criteria observed by standard M Mode,
two-dimensional and Doppler echocardiography [1]: (1)
right atrial collapse and right ventricular diastolic col-
lapse; (2) an inspiratory decrease in peak mitral flow
more than 30% (normal value, <10%), greater than 50%
inspiratory increase in peak tricuspid inflow velocity
(normal value, <25%); (3) dilated vena cava without any
inspiratory collapse; (4) systolic anterior motion of the
mitral valve; (5) swinging of the heart within the pericar-
dium, ‘swinging heart’.
Surgical technique
All patients were operated under general anesthesia with
endotracheal intubation. The pericardium was exposed
via a left minithoracotomy through the fourth intercostal
space (a submammarian incision of 4 to 5 cm) using a
pediatric chest wall retractor. After identification of the
phrenic nerve, an anterolateral pericardial window of
4x4 or 5x5 cm was opened over the left ventricle, or if
the tamponade was due to posterior fluid collection, a
posterior pericardial window below the phrenic nerve
was created. A chest drain (Nu. 28 F) was placed by a
separate incision. The drain was removed after the daily
drainage was reduced to below 100 mL.
Follow-up
The follow-up of the patients were carried out by face-
to-face interviews or over the phone until January 2008.
Recurrence was defined as the subsequent occurrence of
a symptomatic pericardial tamponade after pericardial
window procedure. Survival was defined as the time
from the window procedure until the last visit or time of
death. Follow-up was performed in all patients, and the
mean follow-up duration was 38.86 ± 9.63 months.
Statistical method
Statistical analysis of the data was performed by using
Number Cruncher Statistical System (NCSS) 2007&PASS
2008 statistical software (UT, USA). In addition to descrip-
tive statistical methods, Kruskal Wallis test was used for
the comparison of quantitative variables that were not nor-
mally distributed between the groups. Student t test was
used for the comparison of normally distributed variables
between two groups, and Mann Whitney U test was used
for the comparison of non-normally distributed variables.
The comparison of qualitative variables was performed
using the chi-square test and Fisher’s exact chi-square test.
The Kaplan-Meier method was used for survival analysis.
The prognostic value of the following variables were
investigated: age, sex, primary malignancy, pericardial
effusion-free interval, the amount and type of effusion
drained during surgery, preoperative central venous
pressure (CVP), hemoglobin and ejection fraction (EF)
values, radiotherapy, distant metastasis, the presence
and type of the accompanying pleural effusion, malig-
nant or benign nature of the pericardial tamponade.
Multivariate regression analysis of potential risk factors
affecting long-term survival was performed by Cox
regression analysis. A P value <0.05 was considered sta-
tistically significant.
Results
All patients had a previous diagnosis of cancer. Pericar-
dial tamponade occurred during ongoing chemotherapy
in 32 patients, and after completion of chemotherapy,
either while receiving mediastinal radiotherapy or within
2 months after this procedure, in 13 patients. Three
patients were on simultaneous chemotherapy and radio-
therapy when the tamponade occurred.
The etiology of pericardial effusions is presented in
Table 1. Patient characteristics are presented in Table 2. In
our series, 19 patients with symptomatic pericardial effu-
sion underwent a single pericardiocentesis approximately
30 days before the surgery, and intrapericardial bleomycin
was administered to four of them. However, these patients
were re-admitted to our hospital with clinical signs of
pericardial tamponade, and consequently treated with sur-
gery. All patients in this series consented to undergo sur-
gery. In general, the surgical procedure was well tolerated
by all patients except one who developed hypotension dur-
ing surgery. The operative time was 28.26 ± 3.76 min. The
drainage volume during the operation and the postopera-
tive period were 862.5 ± 390.37 mL and 450± 280 mL, re-
spectively. The highest drainage volume was obtained
from a lung cancer patient with malignant pericardial tam-
ponade, and the lowest drainage volume was obtained
from a cervix cancer patient with an idiopathic pericardial
effusion with tamponade. While 37.5% of the pericardial
effusion was hemorrhagic, 60.4% was serous and 2.1% was
purulent. Pericardial effusion was benign in nature in 22
out of 48 patients (45.8%) and malignant in 26 (54.2%).
No procedure-related mortality was observed in our
study, and the symptomatic recurrence rate was found
as 2.08% (1 patient). The 30-day mortality including in-
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hospital mortality was 8.33% (4 patients). The causes of
30-day mortality were ventricular fibrillation in one pa-
tient, pneumonia and sepsis due to prolonged intubation
in one patient, pulmonary embolism in one patient, and
low cardiac output in another. Morbidity rate was
18.75%. Information regarding morbidity is presented in
Table 3.
In order to improve hemodynamics, pericardiocentesis
was performed in all patients just before the surgery,
and pericardial window was opened subsequently. Symp-
tomatic pericardial effusion recurred 1 month after the
pericardial window procedure in one patient with epi-
dermoid lung cancer (pericardial tamponade due to ir-
radiation), who developed constrictive pericarditis with a
small loculated effusion 1 month after the window pro-
cedure. Pericardiectomy was performed by median ster-
notomy in this patient who died due to low cardiac
output and failure at postoperative day 20.
Survival analysis
Among 48 patients included in the study, four (8.3%) of
them died during the hospitalization period and 36
(75%) died during follow-up. Eight patients (16.7%) were
still alive at the end of the follow-up period. The mean
survival time was 10.41 ± 1.79 months. One-year survival
rate was 45 ± 7% and 2-year survival rate was 18 ± 5%
(Figure 1).
The risk factors affecting survival are presented in
Table 4. Overall survival did not differ significantly
according to sex, the presence, appearance, and the type
of the accompanying pleural effusion, radiotherapy, re-
currence, and the presence of distant metastasis. How-
ever, a statistically significant difference was observed
between the survival durations of patients with various
cancer types (P <0.01). Comparison of paired groups
revealed that survival time in the hematological malig-
nancy group was significantly longer compared to that





























Table 2 Demographic and preoperative data of the patients
Min-Max Mean± SD
Male/female 32/16 64.7/33%
Age (years) 25-73 55.2 + 12.97
Pericardial effusion-free interval (months) 1-48 13.47 ± 10.34
Hb (g/dL) 9.6-16 11.65 ± 1.34
EF (%) 40-66 54.37 ± 5.89











Pericardial effusion type (n)
Malignant 26 54.2
Benign 22 45.8
Accompanying pleural effusion (n) 23 47.9
Malignant 12 52.2
Benign 11 47.8
Radiotherapy prior to or during tamponade 13 27
Chemotherapy prior to or during tamponade 48 100
Distant metastasis 14 35.9
Overt tamponade 48 100
Prior pericardiocentesis 19 40
SD, standard deviation.
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in lung cancer and other cancer groups (P= 0.001 and
P= 0.019, respectively), and survival time in breast can-
cer group was significantly longer compared to that in
lung cancer group (P= 0.014; Figure 2). Patients with
malignant pericardial effusion had a significantly shorter
survival time in compared to that of patients with be-
nign pericardial effusion (P <0.01; Figure 3).
The results of correlation analysis between quantitative
parameters and survival are presented in Table 5.
A statistically significant negative correlation was
found between age and survival time (r =−0.401,
P= 0.005). Survival time decreased with increasing age.
Hemoglobin levels and survival time was positively cor-
related (r = 0.463, P= 0.001). Furthermore, there was a
statistically significant positive correlation between the
pericardial effusion-free interval and survival time
(r = 0.292, P= 0.044). No significant correlation was
noted between survival time and the amount of effusion
removed, preoperative CVP, and EF (P >0.05 for all
parameters).
The variables, which were found to be significant or
close to significance by univariate analysis, were evalu-
ated by Cox regression analysis. Age above 55 years and
lung cancer were found as significant factors affecting
survival. Lung cancer increased the risk of mortality by
1.997-fold (95% CI: 1.004-3.973). Although age was a
significant risk factor, the odds ratio for age was only
0.351 (95% CI: 0.175-0.704) (Table 6).
Assessment of survival rates according to the nature of
pericardial effusion by Log Rank test revealed a significant
Table 3 Operative and postoperative data of the patients
Operative time, min 28.26 ± 3.76
Drainage volume during surgery, mL 862.5 ± 390.37
Postoperative effusion drained, mL 450 ± 280
Duration of drainage, days 6.00 ± 1.46
Postoperative CVP (cmH2O) 9.5 ± 3.2
Length of hospital stay, days 9.5 ± 7.2
30-day mortality 4 (8.33%)
Postoperative complications 7 (14.5%)
Heart failure 1 (2.08%)
Arrhythmia 1 (2.08%)
Pulmonary embolus 1 (2.08%)
Pneumonia 1 (2.08%)
Prolonged ventilation 1 (2.08%)
Wound infection 2 (4.1%)
Follow-up, months 38.86 ± 9.63
Recurrence requiring intervention 1 (2.08%)
CVP, central venous pressure.
Data are given as number (percentage) and Mean± SD, where appropriate.
Figure 1 Survival for all patients.




Female 17.43 ± 9.81 16 0.476
Male 15.07 ± 9.59 11
Cancer typeb
Breast 19.71 ± 6.98 21
Hematologic 29.20 ± 7.59 33 0.001b
Lung 11.79 ± 6.26 11
Other 15.84 ± 11.57 11
Pleural effusion
Present 14.44 ± 8.38 11 0.420
Absent 17.16 ± 10.65 12
Macroscopic appearance of the effusion
Hemorrhagic 13.85 ± 10.12 11 0.136
Serous 17.24 ± 9.39 15
Nature of the pleural effusion
Malignant 14.91 ± 10.6 9.5 0.347
Benign 14.72 ± 6.19 12
Radiotherapy
Present 15.07 ± 8.20 12 0.701
Absent 17.16 ± 11.77 12.5
Distant metastasis
Present 14.73 ± 7.99 11.5 0.942
Absent 14.80 ± 8.41 12
Nature of the pericardial effusion
Malignant 11.89 ± 8.78 9.5 0.004*
Benign 18.36 ± 9.58 16.5
SD, standard deviation.
Mann Whitney U test.
aKruskal Wallis test.
bP <0.01.
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difference (P=0.019; P <0.05). The survival time was
shorter in patients with malignant effusions (Figure 3).
Discussion
Pericardial effusion is less common than pleural effusion
in cancer patients; however, it often has an acute onset,
and may be a direct cause of death if it leads to tampon-
ade, and is not effectively treated. The ideal management
of this life-threatening condition involves urgent decom-
pression of the pericardial cavity, obtaining sufficient
amount of fluid and tissue sample for the identification
of the exact cause of tamponade, prevention of recur-
rence, and targeting a long survival period with the
accomplishment of all of these goals with the lowest pos-
sible morbidity and mortality. Principally, pericardiocen-
tesis procedure does not fulfill these criteria due to high
recurrence rates [2-4]. Recent studies have suggested sur-
gical pericardial window procedure instead of pericardio-
centesis in patients with pulmonary adenocarcinoma who
achieve a longer life expectancy by chemotherapy [5].
Bitran et al. [6] reported that creation of a pericardial win-
dow improved survival time in breast cancer patients who
developed pericardial tamponade. However, it might still
be necessary to perform pericardiocentesis prior to peri-
cardial window procedure to prevent sudden low cardiac
output. It has been reported by Olsen et al. [7] that creat-
ing a pericardial window through left minithoracotomy is
a rapid, simple, and inexpensive technique, which we have
also been routinely performing for a long period of time,
especially in cases of pericardial tamponade. Olsen et al.
[7] created a pericardial window in 28 patients with large
malignant pericardial effusions using this method and
reported that the postoperative mortality was 21%. There
were no procedure-related intra- or postoperative death,
and symptomatic recurrence was noted in only one
patient. We particularly included cancer patients with
pericardial tamponade in our study, as there is currently
no sufficient information or consensus regarding the man-
agement of this condition in cancer patients. Gregory
et al. [8] treated pericardial tamponade by creating a win-
dow through anterolateral thoracotomy in 49 cancer
patients, and reported the in-hospital mortality as 8% and
the rate of recurrence as 6%. We did not observe any
procedure-related mortality in our series and the recur-
rence rate was 2.08%. The 30-day mortality including in-
hospital mortality was 8.33% (4 patients). The patient who
died due to pneumonia and sepsis secondary to prolonged
intubation had both chronic obstructive pulmonary dis-
ease and a body mass index (BMI) >28. Another patient
who died of pulmonary embolism in this group had a pre-
vious history of pulmonary embolism. Death occurred due
to ventricular fibrillation in one patient with a previous
Figure 2 Survival for patients with cancer by tumor type.
Figure 3 Survival for patients with malignant and benign
tamponade.
Table 5 Results of correlation analysis between




Amount of effusion removed during surgery (mL) −0.220 0.134
Preoperative Hb (g/dL) 0.463 0.001a
Preoperative EF (%) 0.193 0.189
Pericardial effusion-free interval (months) 0.292 0.044b
Preoperative CVP (cmH20) 0.174 0.168
CVP, central venous pressure; EF, ejection fraction; Hb, hemoglobin.
R, Spearman’s rho coefficient.
aP <0.01.
bP <0.05.
Celik et al. World Journal of Surgical Oncology 2012, 10:123 Page 5 of 8
http://www.wjso.com/content/10/1/123
history of ischemic heart disease, and low cardiac output
in another patient with chronic ischemic heart disease. No
late pericardial constriction was noted in patients with
long survival rates.
The major reason for preferring left minithoracotomy
for creating a pericardial window in our clinic for years
is that this group of patients need prompt and definitive
diagnosis and treatment. This technique is advantageous
as it does not require single-lung ventilation, it can be
applied in only 25 to 30 min, it provides the opportunity
for opening a larger window, thus allows obtaining a lar-
ger tissue sample with a greater chance of histopatho-
logical diagnosis, and it offers the opportunity for
pleural biopsy. Moreover, mini-submammary incision is
much more cosmetic compared to subxiphoid length-
wise incision. The most important disadvantage of the
technique is the risk of sudden hypotension during in-
duction of general anesthesia, but this risk can be over-
come by a pericardiocentesis performed right before the
procedure. For this reason, echo-guided pericardiocen-
tesis was performed in all patients before the pericardial
window procedure in our study, and no intraoperative
problems were encountered in these patients. Postopera-
tive pain can easily be controlled via a patient-controlled
anesthesia pump. According to our experience, pericar-
dial window procedure is associated with a specific dis-
advantage, which is the difficulty of performing left
minithoracotomy in breast cancer patients with previous
left mastectomy and subsequent radiotherapy. The pres-
ence of excessive adhesions involving the pericardium,
mediastinal tissues and chest wall is highly likely in these
cases, and this might increase the odds of myocardial
rupture during thoracotomy and exploration. Moreover,
it might also be difficult to perform minithoracotomy in
obese individuals and women with large breasts. Other
methods should be considered in these cases.
Video-assisted thoracic surgery (VATS) procedure is
nearly impossible, especially in cases where single-lung
ventilation cannot be performed due to hemodynamic
instability. Actually, the number of studies on VATS
pericardial window in hemodynamically unstable cancer
patients with pericardial tamponade remains limited.
This indicates that the effective use of VATS in this
patient group continue to be a problem. In their study,
Georghiou et al. [9] created a pericardial window via
VATS in 18 patients and stated that VATS had the
advantages of both subxiphoid pericardiotomy and peri-
cardiectomy. In their series, however, there was no
hemodynamically unstable patient with cardiac tampon-
ade. Fibla et al. [10] reported that eight of twelve
patients with cancer who had pericardial tamponade
were treated effectively with VATS. As we apply VATS in
selected patients, these patients have not been included
in the present study.
Although decompression of the pericardial cavity by
subxiphoid approach under local anesthesia is an easier
technique to perform, it is essentially equivalent to tube
thoracostomy, and is associated with high recurrence
rates. Therefore, creating a pericardial window by subxi-
phoid method should not be preferred in patients with a
high probability of long-term survival. In the study by
O’Brien et al. [11], in which subxiphoid approach and
VATS were compared, patients with hemodynamic in-
stability did not constitute the majority. They reported
the recurrence rate of pericardial effusion to be 8% after
VATS. In a prospective study [12] including 30 patients,
of which 15 (10 with tamponade) underwent VATS and
15 (seven with tamponade) underwent surgical proced-
ure (transthoracic or subxiphoid), no significant differ-
ence was found in terms of intra- or postoperative
complications, mortality, duration of drainage, duration
of hospitalization, and recurrence; however, operative
time was reported to be significantly longer in those
undergoing VATS. Becit et al. [13] reported a recurrence
rate of 10% within 1 month of subxiphoid surgical peri-
cardiostomy in 368 patients with pericardial effusions
(most of them had pericarditis associated with tubercu-
losis and uremia) and they created a pericardial window
by left anterior thoracotomy in these patients with no
subsequent recurrence. Mueller et al. [14] reported an
overall success rate of 82% for subxiphoid pericardial
window procedure in their series of 67 patients (26
cancer-related; 14 malignant pericardial effusions). In a
prospective study from Duke University, surgical subxi-
phoid pericardiotomy was done under local anesthesia
in 77% of 57 patients with various diseases, with general
Table 6 Results of univariate and multivarite Cox Regression analysis for potential risk factors affecting survival
Univariate Multivariate (Cox Regression)
P Odds 95% CI P Odds 95% CI
Lower Upper Lower Upper
Age >55 years 0.002a 0.607 0.502 0.885 0.003b 0.351 0.175 0.704
EF <50 0.210 3.769 0.420 33.80 0.221 1.536 0.773 3.055
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anesthesia required in the others. Effusion recurred in
eight patients in 2 months and in nine (16%) in the first
year.
We also found that the presence of malignant pericar-
dial tamponade was a negative risk factor for long-term
survival. Contradictory findings have been reported in pre-
vious studies using various surgical techniques, some sup-
porting [14,15] and some not supporting [16,17] our
results. Wang et al. [18] reported that there was no signifi-
cant difference between survival rates of malignant
(n=60) and benign (n=20) pericardial effusion cases. We
found a significant difference between these groups in our
study. It should also be noted that the overall median sur-
vival found in our study was longer compared to previous
reports. Olsen et al. [7] reported in patients with malig-
nant effusion treated by minithoracotomy pericardial win-
dow that the 6-month survival rate was 46%, the 1-year
survival rate was 26%, and the 2-year survival rate was
15%. These results are similar to the median survival rates
noted in our series. However, the factors affecting survival
were not analyzed in their study.
On the other hand, the use of minimally invasive treat-
ments has been previously studied in this group of
patients; however, these treatments have not been cur-
rently implemented in routine clinical practice due to
various reasons. Drainage with percutaneous catheter in
patients with cardiac tamponade can be applied in the
intensive care units and is a less invasive method. None-
theless, the associated complication and recurrence rates
are high. In their series of 42 patients, Kopecky et al.
[19] reported the complication rate to be 2.4% and the
recurrence rate to be 24%. In the study by Chow et al.
[20], pericardial window formation via percutaneous bal-
loon catheter was defined; however, sufficient experience
has not yet been gained for the use of this method.
The mean survival time in hematological malignancies
was found as 29.20 ± 7.59 (33) months in our study.
Similar results were also reported in studies using subxi-
phoid pericardial window technique [21]. Certainly, the
long survival times in our patients can primarily be
attributed to the advances in systemic treatment. The
high number of cases with solid organ cancers in our
study population can also explain our findings.
Currently, no standardization exists among chest sur-
geons as to which procedure should be used to treat
pericardial tamponade in cancer patients. Based on our
findings, we suggest that creating a pericardial window
by minithoracotomy should be preferred as a definitive
surgical procedure with the lowest recurrence rates, es-
pecially in patients with long-term survival expectancy.
Our study has several limitations including its retro-
spective nature, the relatively small sample size, and het-
erogeneity of the study population, which limits the
generalization of our findings to the general population.
Conclusions
In conclusion, creation of a pleuropericardial window by
left minithoracotomy provides a prompt, safe, and effect-
ive diagnostic and treatment approach, especially in
selected cases of both malignant and benign pericardial
tamponade occurring in cancer patients. Moreover, the
likelihood of recurrence of pericardial effusion is rather
low with this technique. Type of the underlying cancer
and nature of the pericardial effusion were noted as the
main factors affecting long-term survival in our patients.
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